ACADIA Pharmaceuticals(ACAD) Seeking Alpha·2025-05-08 00:10Core Viewpoint - ACADIA Pharmaceuticals is discussing its Q1 2025 financial results and providing updates on its commercial and research activities [3]. Group 1: Company Overview - The conference call is led by Al Kildani, Senior Vice President of Investor Relations and Corporate Communications, with participation from key executives including the CEO, COO, and CFO [2][3]. - The agenda includes opening remarks from the CEO, a discussion on the commercial brand debut in New Plaza by the COO, an update on pipeline programs by the Head of R&D, and a financial review by the CFO [3]. Group 2: Financial Highlights - Financial results for Q1 2025 will be reviewed, highlighting the company's performance and any significant changes compared to previous quarters [3].